Half-year report · HY
9158.TEDINET S100X3FV
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥26.3bn | 2025-04-01 → 2025-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥47.0bn | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥21.6bn | 2024-04-01 → 2024-09-30 | Cons. | Revenue IFRS |
| Operating income | ¥1.7bn | 2025-04-01 → 2025-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥3.0bn | 2024-04-01 → 2024-09-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥1.4bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥5.2bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥3.2bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥612m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥3.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥2.0bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥566m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥2.0bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss IFRS |
| Total assets | ¥94.1bn | at 2025-09-30 | Cons. | Assets IFRS |
| Total assets | ¥85.2bn | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥70.2bn | at 2024-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥63.4bn | at 2025-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥54.9bn | at 2025-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥30.7bn | at 2025-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥30.3bn | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥28.5bn | at 2024-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥28.0bn | at 2024-03-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥30.2bn | at 2025-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥29.7bn | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥27.9bn | at 2024-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥13.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥7.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥13.2bn | at 2024-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥8.3bn | at 2024-03-31v | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥2.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥1.9bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥3.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥4.5bn | 2024-04-01 → 2025-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥2.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥6.9bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥7.6bn | 2024-04-01 → 2025-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥5.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥20.89 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥106.81 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥68.51 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥20.89 | 2025-04-01 → 2025-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥106.81 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥68.51 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 32.0% | at 2025-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 34.8% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 39.8% | at 2024-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 52
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥41m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥41m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | −¥10m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥226m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥226m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥454m |
| Hospicereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥7.9bn |
| Hospicereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥7.9bn |
| Hospicereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥139m |
| In Home Nursingreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥6.5bn |
| In Home Nursingreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥6.5bn |
| In Home Nursingreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥3m |
| In Home Nursingreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥657m |
| Management Supportreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥8.2bn |
| Management Supportreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥8.0bn |
| Management Supportreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥223m |
| Management Supportreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥1.5bn |
| Medical Care Residencereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥3.8bn |
| Medical Care Residencereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥3.8bn |
| Medical Care Residencereportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥96m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥26.5bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥26.3bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥226m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥26.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥26.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥226m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥83m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥83m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥55m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥157m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥157m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥439m |
| Hospicereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥6.7bn |
| Hospicereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥6.7bn |
| Hospicereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥690m |
| In Home Nursingreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥6.1bn |
| In Home Nursingreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥6.1bn |
| In Home Nursingreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥540m |
| Management Supportreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥8.9bn |
| Management Supportreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥8.7bn |
| Management Supportreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥157m |
| Management Supportreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2.2bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥21.7bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥21.5bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥157m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥3.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥21.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥21.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥157m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥3.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 851
| Item | Context | Value | Unit |
|---|---|---|---|
| Name major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)株式会社日本カストディ銀行（信託口） | |
| Address major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)東京都中央区晴海一丁目８番12号 | |
| Name major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)株式会社日本政策投資銀行 | |
| Address major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)東京都千代田区大手町一丁目９番６号 | |
| Name major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)BBH CO FOR ARCUS JAPAN VALUE FUND（常任代理人 株式会社三菱UFJ銀行） | |
| Address major shareholders | InterimInstant_No5MajorShareholdersMember | Text · Plus | |
| Name major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)RE FUND 107-CLIENT AC（常任代理人 シティバンク エヌ・エイ東京支店） | |
| Address major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)MINISTRIES COMPLEX ALMURQAB AREA KUWAIT（東京都新宿区新宿六丁目27番30号） | |
| Name major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)田邉 隆通 | |
| Address major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)東京都世田谷区 | |
| Name major shareholders | InterimInstant_No8MajorShareholdersMember | Text · Plus | |
| Address major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)80 ROUTE D'ESCH LUXEMBOURG LUXEMBOURG（東京都千代田区丸の内一丁目１番２号） | |
| Name major shareholders | InterimInstant_No9MajorShareholdersMember | Text · Plus | |
| Address major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)245 SUMMER STREET, BOSTON, MA 02210, USA（東京都新宿区新宿六丁目27番30号） | |
| Name major shareholders | InterimInstant_No10MajorShareholdersMember | Text · Plus | |
| Address major shareholders | InterimInstant_No10MajorShareholdersMember | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)株式会社シーユーシー | |
| Address of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)東京都港区芝浦三丁目１番１号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Description of fact that consolidated financial statements have been prepared in accordance with IFRS financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Condensed semi annual consolidated statement of financial position IFRS (text) | InterimDuration | Text · Plus | |
| Condensed semi annual consolidated statement of profit or loss IFRS (text) | InterimDuration | Text · Plus | |
| Condensed semi annual consolidated statement of comprehensive income IFRS (text) | InterimDuration | Text · Plus | |
| Condensed semi annual consolidated statement of changes in equity IFRS (text) | InterimDuration | Text · Plus | |
| Condensed semi annual consolidated statement of cash flows IFRS (text) | InterimDuration | Text · Plus | |
| Notes reporting entity condensed semi annual consolidated financial statements IFRS (text) | InterimDuration | Text · Plus | |
| Notes basis of preparation condensed semi annual consolidated financial statements IFRS (text) | InterimDuration | Text · Plus | |
| Notes significant accounting policies condensed semi annual consolidated financial statements IFRS (text) | InterimDuration | Text · Plus | |
| Notes significant accounting estimates and judgements condensed semi annual consolidated financial statements IFRS (text) | InterimDuration | Text · Plus | |
| Notes segment information condensed semi annual consolidated financial statements IFRS (text) | InterimDuration | Text · Plus | |
| Disclosure of changes in reportable segments IFRS (text) | InterimDuration | Text · Plus | |
| Notes business combinations condensed semi annual consolidated financial statements IFRS (text) | InterimDuration | Text · Plus | |
| Notes borrowings condensed semi annual consolidated financial statements IFRS (text) | InterimDuration | Text · Plus | |
| Notes share capital and other equity items condensed semi annual consolidated financial statements IFRS (text) | InterimDuration | Text · Plus | |
| Notes dividends condensed semi annual consolidated financial statements IFRS (text) | InterimDuration | Text · Plus | |
| Notes revenue condensed semi annual consolidated financial statements IFRS (text) | InterimDuration | Text · Plus | |
| Notes earnings per share condensed semi annual consolidated financial statements IFRS (text) | InterimDuration | Text · Plus | |
| Notes fair value of financial instruments condensed semi annual consolidated financial statements IFRS (text) | InterimDuration | Text · Plus | |
| Notes related parties condensed semi annual consolidated financial statements IFRS (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |